Nobivac Feline 1-HCPCh + FeLV Vaccine

Supplied By: Merck (065267)


SKU
006489


Unit of
Measure 25 x 1 Dose


Pack
Type Box


Case
Qty 10

Login
{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}
Apr- 2024 Mar- 2024 Feb- 2024 Jan- 2024 Dec- 2023 Nov- 2023 Oct- 2023 Sep- 2023 Aug- 2023 Jul- 2023 Jun- 2023 May- 2023 Apr- 2023
{{purchaseHistoryItem}}


SKU 006489


Size 25 x 1 Dose

Case
Qty 10

Purchase History

Apr- 2024 {{productPurchaseHistory['006489'][0]}} Sep- 2023 {{productPurchaseHistory['006489'][0+7]}}
Mar- 2024 {{productPurchaseHistory['006489'][1]}} Aug- 2023 {{productPurchaseHistory['006489'][1+7]}}
Feb- 2024 {{productPurchaseHistory['006489'][2]}} Jul- 2023 {{productPurchaseHistory['006489'][2+7]}}
Jan- 2024 {{productPurchaseHistory['006489'][3]}} Jun- 2023 {{productPurchaseHistory['006489'][3+7]}}
Dec- 2023 {{productPurchaseHistory['006489'][4]}} May- 2023 {{productPurchaseHistory['006489'][4+7]}}
Nov- 2023 {{productPurchaseHistory['006489'][5]}} Apr- 2023 {{productPurchaseHistory['006489'][5+7]}}
Oct- 2023 {{productPurchaseHistory['006489'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}
Login

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Product Description

Nobivac Feline 1-HCPCh+FeLV is a core vaccine that works to protect cats from several viruses (rhinotracheitis, calicivirus, and panleukopenia), along with feline leukemia and chlamydophila felis.

Features & Benefits

  • A quality core vaccine that protects against feline rhinotracheitis, feline panleukopenia virus (FPV), feline calicivirus (FCV), and feline Chlamydophila in addition to providing extensive 2-year immunity coverage for feline leukemia
  • Nobivac® Feline 1-HCP has been shown to block the replication of canine parvovirus (CPV) in cats
  • Evidence shows that CPV-2a, CPV-2b, and CPV-2c isolates can replicate in cats, producing clinical signs of feline panleukopenia
  • The only feline leukemia vaccine labeled to prevent persistent viremia for 2 years after vaccination
  • 96% of vaccinated cats were protected against persistent viremia after FeLV challenge
  • In a 2-year study involving 23 FeLV-negative cats:
  • After 12 weeks, 83% of vaccinates were free of persistent and transient viremia
  • All 11 control cats (100%) developed persistent viremia
  • Results showed that cats developed immunity solely through the initial vaccination series
  • Optimal choice for outdoor cats and cats that are boarded frequently